The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis

The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis

<i>Background and Objectives:</i> Iron deficiency and anemia characterize patients on chronic hemodialysis (HD). Available intravenous iron agents, such as ferric gluconate (FG) and ferric carboxymaltose (FCM), vary in dosing regimens and safety profiles. The aim of the present study was...

Full description

Bibliographic Details
Main Authors: Antonio Lacquaniti, Romana Gargano, Susanna Campo, Teresa Casuscelli di Tocco, Silvia Schifilliti, Paolo Monardo
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Medicina
Subjects:
erythropoietin resistance index
ferric carboxymaltose
pharmacoeconomics
ESA
transferrin saturation
Online Access:https://www.mdpi.com/1648-9144/59/6/1071

Internet

https://www.mdpi.com/1648-9144/59/6/1071

Similar Items